VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Bio-Rad Laboratories, Inc. (BIO) Total Return Calculator with Dividends Reinvested

Bio-Rad Laboratories, Inc.

Popular:

The total return for Bio-Rad Laboratories, Inc. (BIO) stock is +11.85% over the past 12 months. So far it's down 15.15% this year. The 5-year total return is -56.99%, meaning $10,000 invested in BIO stock 5 years ago would be worth $4,301 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in BIO 1 year ago, it would be worth $11,185 today — you'd have gained $1,185.

With Dividends Reinvested$11,185+11.85%

Price Only (No DRIP)$11,185+11.85%

Period2025-05-06 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in BIO

1Y$11,185+$1,185 (+11.9%)11.9% CAGR

3Y$6,845-$3,155 (-31.5%)-11.9% CAGR

5Y$4,301-$5,699 (-57.0%)-15.5% CAGR

10Y$18,288+$8,288 (+82.9%)6.2% CAGR

15Y$21,048+$11,048 (+110.5%)5.1% CAGR

20Y$36,746+$26,746 (+267.5%)6.7% CAGR

30Y$158,988+$148,988 (+1489.9%)9.7% CAGR

Bio-Rad Laboratories, Inc. did not pay dividends during this period. Total return = price return.

Loading BIO total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-15.15%	—	-15.15%	—	$8,485
1Y	+11.85%	11.85%	+11.85%	—	$11,185
3Y	-31.55%	-11.87%	-31.55%	—	$6,845
5Y	-56.99%	-15.53%	-56.99%	—	$4,301
10Y	+82.88%	6.22%	+82.88%	—	$18,288
15Y	+110.48%	5.09%	+110.48%	—	$21,048
20Y	+267.46%	6.72%	+267.46%	—	$36,746
30Y	+1489.88%	9.66%	+1489.88%	—	$158,988

Risk & Highlights

Best Year+97.20%2001

Worst Year-42.82%2022

Max Drawdown-24.49%2025-10-24 → 2026-05-01

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-8.79%	-8.79%	—	+0.41%	-9.2pp
2025	-7.10%	-7.10%	—	+16.64%	-23.7pp
2024	+0.16%	+0.16%	—	+24.00%	-23.8pp
2023	-23.56%	-23.56%	—	+24.81%	-48.4pp
2022	-42.82%	-42.82%	—	-19.95%	-22.9pp

BIO underperformed the S&P 500 by 19.47pp over the past year (+11.85% vs +31.32%).

Loading summary...

BIO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
BIOBio-Rad Laboratories, Inc.	$7.0B	-7.1%	-15.2%	+11.9%	—	-31.5%	-57.0%	+82.9%
TMOThermo Fisher Scientific Inc.	$175.8B	-3.1%	-20.1%	+16.6%	+0.4pp	-11.9%	+2.1%	+229.1%
DHRDanaher Corporation	$123.8B	-9.0%	-23.9%	-7.2%	+0.7pp	-15.9%	-20.9%	+218.0%
BRKRBruker Corporation	$6.4B	+15.1%	-12.0%	+7.7%	+0.5pp	-44.4%	-36.6%	+59.6%
RGENRepligen Corporation	$7.1B	+7.5%	-23.5%	-3.6%	—	-19.7%	-32.1%	+379.1%
CRLCharles River Laboratories International, Inc.	$9.0B	+8.0%	-10.2%	+57.5%	—	-4.3%	-46.0%	+124.7%
IDXXIDEXX Laboratories, Inc.	$46.1B	+0.3%	-13.5%	+22.3%	—	+19.3%	+8.6%	+568.9%
HOLXHologic, Inc.	$17.0B	+0.0%	+1.9%	+43.1%	—	-8.5%	+16.7%	+125.4%
QGENQiagen N.V.	$7.1B	-15.5%	-18.7%	-12.3%	+6.0pp	-18.8%	-21.6%	+70.4%
AZTAAzenta, Inc.	$847M	-18.6%	-45.0%	-27.7%	—	-59.5%	-80.3%	+121.7%
NVCRNovoCure Limited	$1.9B	+56.4%	+25.7%	+1.0%	—	-76.2%	-91.5%	+31.0%

Compare:BIO vs TMO BIO vs DHR BIO vs BRKR BIO vs TMO vs DHR

About BIO Dividend Returns

Bio-Rad Laboratories, Inc. (BIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of BIO over the past year?

Bio-Rad Laboratories, Inc. (BIO) delivered a return of 11.85% over the past year. Since BIO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in BIO be worth today?

A $10,000 investment in Bio-Rad Laboratories, Inc. one year ago would be worth $11,185 today, representing a gain of $1,185.

Q3Does BIO pay dividends?

Bio-Rad Laboratories, Inc. (BIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BIO, the total return equals the price-only return.

Q4Did BIO beat the S&P 500?

No, Bio-Rad Laboratories, Inc. (BIO) underperformed the S&P 500 by 19.47 percentage points over the past year. BIO delivered a total return of 11.85%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed BIO by 19.47pp during this period.

Q5What is BIO's worst drawdown?

Bio-Rad Laboratories, Inc. (BIO) experienced a maximum drawdown of -24.49% over the past year, declining from its peak on 2025-10-24 to its trough on 2026-05-01. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is BIO's long-term total return over 10, 20, or 30 years?

Here are Bio-Rad Laboratories, Inc. (BIO)'s long-term returns with dividends reinvested. Over 10 years, the total return is 82.9% (6.2% CAGR) — $10,000 would have grown to $18,288. Over 20 years: 267.5% total return (6.7% CAGR) — $10,000 → $36,746. Over 30 years: 1489.9% total return (9.7% CAGR) — $10,000 → $158,988. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was BIO's best and worst year?

Bio-Rad Laboratories, Inc.'s best calendar year was 2001 with a total return of 97.2%. Its worst year was 2022 with a total return of -42.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 140.0 percentage points.